ResMed welcomed positive results from the independent Home Oxygen
Therapy- Home Mechanical Ventilation (HOT-HMV) study[i] regarding the
benefits of home non-invasive ventilation (NIV). Portable oxygen
therapy, remote monitoring technology and home NIV are key components of
ResMed’s COPD management offering.
The
HOT-HMV study shows that the addition of home NIV to home oxygen
therapy improves admission-free survival in hypercapnic COPD patients
(those with high levels of carbon dioxide in the blood) following a
life-threatening exacerbation of COPD requiring acute NIV.1 This
includes an increase in patients’ median (hospital) admission-free
survival from 1.4 months in the group receiving HOT only, to 4.3 months
in the group receiving HOT plus home NIV, with an adjusted hazard ratio
of 0.49 (0.31-0.77); p=0.002.
ResMed home NIV solutions are also connected to AirView™, ResMed’s
cloud-based patient management system, which ensures healthcare
professionals can remotely identify patients in need of attention, make
informed treatment decisions and deliver timely interventions. In
addition to helping physicians better manage COPD patients on home NIV,
AirView also enables home care providers to optimise business
efficiencies and allows them to focus existing resources on high-value
activities. Resmed’s cloud-connected ventilators provide peace of mind
to patients and their families and help improve their overall experience
living with COPD.
A press release can be found from ResMed website.
No comments:
Post a Comment